Normative values of muscle strength across ages in a 'real world' population: results from the longevity check-up 7+ project.
Chair-stand test
EWGSOP2
Early diagnosis
Handgrip strength
Sarcopenia
Screening
Journal
Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
29
04
2020
revised:
07
07
2020
accepted:
26
07
2020
pubmed:
5
11
2020
medline:
29
10
2021
entrez:
4
11
2020
Statut:
ppublish
Résumé
Low muscle strength is a powerful predictor of negative health-related events and a key component of sarcopenia. The lack of normative values for muscle strength across ages hampers the practical appraisal of this parameter. The aim of the present study was to produce normative values for upper and lower extremity muscle strength across a wide spectrum of ages, in a large sample of community-dwellers recruited in the Longevity check-up (Lookup) 7+ project. Lookup 7+ is an ongoing project that started in June 2015 and conducted in unconventional settings (i.e. exhibitions, malls, and health promotion campaigns) across Italy with the aim of fostering the adoption of healthy lifestyles in the general population. Candidate participants are eligible for enrolment if they are 18+ years and provide written informed consent. Upper and lower extremity muscle strength is assessed by handgrip strength and five-repetition chair-stand [5 × sit-to-stand (STS)] tests, respectively. Cross-sectional centile and normative values for handgrip strength and 5 × STS tests from age 18 to 80+ years were generated for the two genders. Smoothed normative curves for the two tests were constructed for men and women using the lambda-mu-sigma method. From 1 June 2015 to 30 May 2019, 11 448 participants were enrolled. The mean age of participants was 55.6 years (standard deviation: 11.5 years; range: 18-98 years), and 6382 (56%) were women. Normative values for handgrip strength and the 5 × STS test, both absolute and normalized by body mass index, were obtained for men and women, stratified by age groups. Values of upper and lower extremity muscle strength across ages identified three periods in life: an increase to peak in young age and early adulthood (18-24 years), preservation through midlife (25-44 years), and a decline from midlife onwards (45+ years). Our study established age-specific and gender-specific percentile reference values for handgrip strength and the 5 × STS test. The normative curves generated can be used to interpret the assessment of muscle strength in everyday practice for the early detection of individuals with or at risk of sarcopenia.
Sections du résumé
BACKGROUND
Low muscle strength is a powerful predictor of negative health-related events and a key component of sarcopenia. The lack of normative values for muscle strength across ages hampers the practical appraisal of this parameter. The aim of the present study was to produce normative values for upper and lower extremity muscle strength across a wide spectrum of ages, in a large sample of community-dwellers recruited in the Longevity check-up (Lookup) 7+ project.
METHODS
Lookup 7+ is an ongoing project that started in June 2015 and conducted in unconventional settings (i.e. exhibitions, malls, and health promotion campaigns) across Italy with the aim of fostering the adoption of healthy lifestyles in the general population. Candidate participants are eligible for enrolment if they are 18+ years and provide written informed consent. Upper and lower extremity muscle strength is assessed by handgrip strength and five-repetition chair-stand [5 × sit-to-stand (STS)] tests, respectively. Cross-sectional centile and normative values for handgrip strength and 5 × STS tests from age 18 to 80+ years were generated for the two genders. Smoothed normative curves for the two tests were constructed for men and women using the lambda-mu-sigma method.
RESULTS
From 1 June 2015 to 30 May 2019, 11 448 participants were enrolled. The mean age of participants was 55.6 years (standard deviation: 11.5 years; range: 18-98 years), and 6382 (56%) were women. Normative values for handgrip strength and the 5 × STS test, both absolute and normalized by body mass index, were obtained for men and women, stratified by age groups. Values of upper and lower extremity muscle strength across ages identified three periods in life: an increase to peak in young age and early adulthood (18-24 years), preservation through midlife (25-44 years), and a decline from midlife onwards (45+ years).
CONCLUSIONS
Our study established age-specific and gender-specific percentile reference values for handgrip strength and the 5 × STS test. The normative curves generated can be used to interpret the assessment of muscle strength in everyday practice for the early detection of individuals with or at risk of sarcopenia.
Identifiants
pubmed: 33147374
doi: 10.1002/jcsm.12610
pmc: PMC7749608
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1562-1569Informations de copyright
© 2020 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders.
Références
Aging Clin Exp Res. 2013 Jun;25(3):305-9
pubmed: 23740582
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1143-1145
pubmed: 31661195
J Pediatr Orthop B. 2001 Oct;10(4):352-4
pubmed: 11727383
J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):535-546
pubmed: 27104109
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):84-94
pubmed: 30371008
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):956-961
pubmed: 31523937
J Am Med Dir Assoc. 2018 Aug;19(8):703-709
pubmed: 29935982
Calcif Tissue Int. 2019 Jul;105(1):1-14
pubmed: 30972475
Exp Gerontol. 2018 Feb;102:76-80
pubmed: 29246506
PLoS One. 2014 Dec 04;9(12):e113637
pubmed: 25474696
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):155-164
pubmed: 30499245
J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):269-278
pubmed: 29349935
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):907-914
pubmed: 28913934
Stat Med. 1992 Jul;11(10):1305-19
pubmed: 1518992
J Am Med Dir Assoc. 2017 Jan;18(1):88.e17-88.e24
pubmed: 27914849
J Nutr Health Aging. 2017;21(9):1050-1056
pubmed: 29083447
BMJ. 2000 May 6;320(7244):1240-3
pubmed: 10797032
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58
pubmed: 24737557
Eur J Public Health. 2013 Oct;23(5):858-62
pubmed: 24078648
J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):512-514
pubmed: 27891296
J Cachexia Sarcopenia Muscle. 2020 Feb;11(1):3-25
pubmed: 31788969
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Am J Occup Ther. 1986 Oct;40(10):705-11
pubmed: 3777107
J Am Med Dir Assoc. 2013 Oct;14(10):775.e5-11
pubmed: 23958225
J Nutr Health Aging. 2008 Aug-Sep;12(7):427-32
pubmed: 18615224
Clin Geriatr Med. 2015 Aug;31(3):367-74
pubmed: 26195096
Clin Orthop Relat Res. 2010 Jan;468(1):217-23
pubmed: 19459024
J Cachexia Sarcopenia Muscle. 2017 Aug;8(4):598-606
pubmed: 28474432
Eur J Public Health. 2018 Aug 1;28(4):766-772
pubmed: 29554257
Exp Gerontol. 2018 Nov;113:48-57
pubmed: 30261246
J Gerontol A Biol Sci Med Sci. 2005 Jan;60(1):74-9
pubmed: 15741286
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
J Cachexia Sarcopenia Muscle. 2020 Feb;11(1):38-45
pubmed: 31800168
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1562-1569
pubmed: 33147374